Free Trial Information
BioCentury | Nov 16, 2015
Financial News

Recardio completes venture financing

Recardio Inc. , San Francisco, Calif. Business: Cardiovascular Date completed: 2015-11-11 Type: Venture financing Raised: $3 million Investors: Existing investor; new investors WIR Staff Cardiovascular...
Read More
BioCentury | Apr 7, 2014
Emerging Company Profile

Recardio: Cardiac regeneration

...than 20% of patients progress to heart failure within six years of a heart attack. Recardio's...
...and improves myocardial function. G-CSF stimulates the release of progenitor cells from the bone marrow. Recardio...
...may benefit patients with congestive heart failure, but Recardio is first pursuing the MI indication. Recardio...
Read More
Items per page:
1 - 2 of 2
BioCentury | Nov 16, 2015
Financial News

Recardio completes venture financing

Recardio Inc. , San Francisco, Calif. Business: Cardiovascular Date completed: 2015-11-11 Type: Venture financing Raised: $3 million Investors: Existing investor; new investors WIR Staff Cardiovascular...
Read More
BioCentury | Apr 7, 2014
Emerging Company Profile

Recardio: Cardiac regeneration

...than 20% of patients progress to heart failure within six years of a heart attack. Recardio's...
...and improves myocardial function. G-CSF stimulates the release of progenitor cells from the bone marrow. Recardio...
...may benefit patients with congestive heart failure, but Recardio is first pursuing the MI indication. Recardio...
Read More
Items per page:
1 - 2 of 2